Alpha Tau Medical Ltd. (NASDAQ:DRTSW – Get Free Report) was up 14.3% during trading on Friday . The company traded as high as $0.41 and last traded at $0.40. Approximately 6,992 shares traded hands during trading, a decline of 87% from the average daily volume of 52,226 shares. The stock had previously closed at $0.35.
Alpha Tau Medical Stock Performance
The firm’s fifty day moving average price is $0.26 and its two-hundred day moving average price is $0.22.
About Alpha Tau Medical
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. The company's Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; preclinical or pending clinical studies for brain and other cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others.
See Also
- Five stocks we like better than Alpha Tau Medical
- Top Stocks Investing in 5G Technology
- MP Materials: Rare Earth Elements Powering the EV Boom
- Consumer Discretionary Stocks Explained
- Verizon’s Turnaround Gains Traction: New Highs Are Likely in 2025
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Bloom Energy: Powering the Future With Decentralized Energy
Receive News & Ratings for Alpha Tau Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Tau Medical and related companies with MarketBeat.com's FREE daily email newsletter.
